Detalles de la búsqueda
1.
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression.
Ann Rheum Dis
; 83(4): 464-474, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233103
2.
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation.
J Autoimmun
; 143: 103159, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38141420
3.
Neuropsychiatric symptoms in Systemic Lupus Erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project.
Rheumatology (Oxford)
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518094
4.
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study.
Rheumatology (Oxford)
; 2024 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402539
5.
Systemic lupus erythematosus: one year in review 2024.
Clin Exp Rheumatol
; 42(3): 583-592, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545801
6.
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.
Ann Rheum Dis
; 82(10): 1248-1257, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37495237
7.
Systemic lupus erythematosus: one year in review 2023.
Clin Exp Rheumatol
; 41(5): 997-1008, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133502
8.
Novel insights into the management of rheumatoid arthritis: one year in review 2023.
Clin Exp Rheumatol
; 41(11): 2129-2141, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37497719
9.
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus.
Clin Exp Rheumatol
; 41(1): 145-150, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35894063
10.
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study.
Clin Exp Rheumatol
; 41(3): 628-633, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930471
11.
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.
Clin Exp Rheumatol
; 41(3): 543-553, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36916322
12.
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis.
Int J Mol Sci
; 24(5)2023 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902437
13.
Very low prevalence of ultrasound-detected tenosynovial abnormalities in healthy subjects throughout the age range: OMERACT ultrasound minimal disease study.
Ann Rheum Dis
; 81(2): 232-236, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407928
14.
One year in review 2022: systemic lupus erythematosus.
Clin Exp Rheumatol
; 40(1): 4-14, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088691
15.
Novel insights into the management of rheumatoid arthritis: one year in review 2022.
Clin Exp Rheumatol
; 40(7): 1247-1257, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35801648
16.
Impact of disease duration and gender on the sensitivity and specificity of 2015 ACR/EULAR classification criteria for gout. Cross-sectional results from an Italian multicentric study on the management of crystal-induced arthritis (ATTACk).
Clin Exp Rheumatol
; 40(7): 1368-1377, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34665701
17.
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
Clin Exp Rheumatol
; 40 Suppl 134(5): 3-11, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349419
18.
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
Ann Rheum Dis
; 80(6): 758-766, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33568388
19.
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
J Autoimmun
; 124: 102729, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34600347
20.
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review.
Rheumatology (Oxford)
; 61(1): 8-23, 2021 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788917